1. Home
  2. ALH vs ADPT Comparison

ALH vs ADPT Comparison

Compare ALH & ADPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alliance Laundry Holdings Inc.

ALH

Alliance Laundry Holdings Inc.

N/A

Current Price

$23.65

Market Cap

5.1B

Sector

Industrials

ML Signal

N/A

Logo Adaptive Biotechnologies Corporation

ADPT

Adaptive Biotechnologies Corporation

N/A

Current Price

$29.22

Market Cap

4.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ALH
ADPT
Founded
1908
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.1B
4.5B
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
ALH
ADPT
Price
$23.65
$29.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
8
Target Price
$31.00
★ $32.57
AVG Volume (30 Days)
832.5K
★ 2.0M
Earning Date
11-10-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 63.89
EPS
★ 0.94
N/A
Revenue
★ $1,709,237,000.00
$276,976,000.00
Revenue This Year
$6.72
$10.85
Revenue Next Year
$6.52
$21.60
P/E Ratio
$25.42
★ N/A
Revenue Growth
13.31
★ 54.77
52 Week Low
$18.64
$12.00
52 Week High
$28.23
$32.21

Technical Indicators

Market Signals
Indicator
ALH
ADPT
Relative Strength Index (RSI) 58.32 58.55
Support Level $23.20 $24.02
Resistance Level $25.43 $29.92
Average True Range (ATR) 0.88 1.83
MACD 0.21 0.35
Stochastic Oscillator 56.83 60.05

Price Performance

Historical Comparison
ALH
ADPT

About ALH Alliance Laundry Holdings Inc.

Alliance Laundry Holdings Inc is a designer and manufacturer of commercial laundry systems, serving diverse international markets. The company offers premium, durable laundry equipment under brands like Speed Queen, UniMac, Huebsch, Primus, IPSO, and others. It serves commercial laundry needs across healthcare, hotels, laundromats, and residential markets. Revenue is generated through the sale of commercial-grade laundry systems and service parts across two geographic segments, North America and International, and into the three end markets of OPL, Vended, and Commercial In-Home.

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.

Share on Social Networks: